Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB19364ApprovedWithdrawnSmall molecule
Azaribine: Overview.
- Mechanism
- Curator reviewed
Pharmacologically active on Uridine 5'-monophosphate synthase
- Formula / weight
- C14H17N3O9 · 371.302 g/mol (avg)
- Also known as
- 1,2,4-triazine-3,5(2h,4h)-dione, 2-(2,3,5-tri-o-acetyl-.beta.-d-ribofuranosyl)- · 2-.beta.-d-ribofuranosyl-as-triazine-3,5(2h,4h)-dione 2',3',5'-triacetate · 6-azauridine 2',3',5'-triacetate · Triazure
- Code names
- CB-304 · NSC-67239
Resolves to
Structure
InChIKey
QQOBRRFOVWGIMD-OJAKKHQRSA-NSMILESCC(=O)OC[C@H]1O[C@H]([C@H](OC(C)=O)[C@@H]1OC(C)=O)N1N=CC(=O)NC1=OTargets
What you can answer from here — as of September 13, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
Which drugs share a target with Azaribine, and which of those have an active Phase 3 trial?